Raymond James & Associates increased its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 14.5% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 49,615 shares of the technology company’s stock after purchasing an additional 6,267 shares during the quarter. Raymond James & Associates’ holdings in Simulations Plus were worth $1,104,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. boosted its holdings in Simulations Plus by 12.4% in the 2nd quarter. BlackRock Inc. now owns 846,454 shares of the technology company’s stock worth $18,833,000 after acquiring an additional 93,438 shares during the period. Millennium Management LLC purchased a new position in Simulations Plus in the 1st quarter worth approximately $752,000. Russell Investments Group Ltd. boosted its holdings in Simulations Plus by 105.3% in the 1st quarter. Russell Investments Group Ltd. now owns 81,342 shares of the technology company’s stock worth $1,200,000 after acquiring an additional 41,728 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Simulations Plus by 8.6% in the 1st quarter. Dimensional Fund Advisors LP now owns 475,216 shares of the technology company’s stock worth $7,009,000 after acquiring an additional 37,811 shares during the period. Finally, Renaissance Technologies LLC boosted its holdings in Simulations Plus by 6.4% in the 2nd quarter. Renaissance Technologies LLC now owns 592,100 shares of the technology company’s stock worth $13,174,000 after acquiring an additional 35,600 shares during the period. 35.70% of the stock is owned by hedge funds and other institutional investors.
A number of research firms have weighed in on SLP. BidaskClub upgraded Simulations Plus from a “hold” rating to a “buy” rating in a report on Tuesday. Zacks Investment Research cut Simulations Plus from a “buy” rating to a “hold” rating in a research note on Thursday, June 28th. Finally, ValuEngine cut Simulations Plus from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 11th.
In other news, Chairman Walter S. Woltosz sold 18,500 shares of the stock in a transaction that occurred on Monday, August 27th. The stock was sold at an average price of $20.33, for a total transaction of $376,105.00. Following the completion of the transaction, the chairman now directly owns 5,436,408 shares in the company, valued at approximately $110,522,174.64. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Over the last quarter, insiders have sold 55,500 shares of company stock valued at $1,073,185. Company insiders own 33.45% of the company’s stock.
About Simulations Plus
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Featured Article: Is the Dow Jones Industrial Average (DJIA) still relevant?
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.